Mavixen 100/40mg Tablet (Glecaprevir/Pibrentasvir)
Prescription RequiredManufactured By
Everest
Pack Of
21
Salt Composition
Glecaprevir/Pibrentasvir
Storage
Keep in cold place
ALL SUBSTITUTES
Maviret Tablet
Overview
Mavixen 100/40mg Tablets is a prescription-based medicine used in the treatment of chronic hepatitis C virus (HCV) infection in patients matured 12 years and older. The active ingredient of the Mavixen 100/40mg Tablet is glecaprevir and pibrentasvir which belongs to the drug class of HCV NS3/4A protease inhibitors.
Together, these salts inhibit the hepatitis C virus's ability to replicate. Because Mavixen Tablet lowers the quantity of viruses in your body, it may help in the removal of the virus.
Quick Product Facts
| Field | Publication wording |
|---|---|
| Brand | mavixen |
| Generic / Active Ingredient | Glecaprevir/Pibrentasvir |
| Strength | 100 |
| Dosage Form | Tablet |
| Manufacturer / Marketer | Everest |
| Pack Size | 21 |
| Prescription Required | Yes |
| Therapeutic Categories | Hepatitis Medicines |
| Uses | Hepatitis-C |
Uses and Indications
Head and neck cancer, kidney cancer, lung cancer, liver cancer, skin cancer
Side Effects of Mavixen 100/40mg Tablet
The human body shows undesired symptoms after taking Glecaprevir and pibrentasvir (Mavixen 100/40mg Tablet). Usually, they disappear with time as the body adjusts to the medicine. These side effects don't need special medical attention. It is advised to consult your doctor if these symptoms become unmanageable.
Common or Clinically Frequent Side Effects
- Some of the common side effects of Mavixen Tablet are mentioned below:
- ● Fever
- ● Headache
- ● Joint pain
- ● Tiredness
- ● Dark stools
- ● Breathlessness
- ● Loss of appetite
- ● Abdominal pain
- ● Skin inflammation
- ● Nausea & vomiting
- ● Yellowing of skin and eye
- ● Swelling of the face, lips, and mouth
Mavixen 100/40mg Tablet Dosage and How To Take It
Take Mavixen 100/40mg Tablet in dosage as prescribed by the doctor. Dosage and the duration determined as per the patients health condition. This tablet should be swallowed as a whole with water. Don't crush, chew, or break the tablet. It should be taken with food. Never skip a dose or double dose.
Safety Advice for Mavixen 100/40mg Tablet
- • Alcohol: The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking Glecaprevir and pibrentasvir (Mavixen 100/40mg Tablet). It is advised to consult your doctor for further information.
- • Pregnancy: Mavixen 100/40mg Tablet (glecaprevir and pibrentasvir) may be considered unsafe during pregnancy. Please consult your doctor in such condition.
- • Breastfeeding: Mavixen 100/40mg Tablet (glecaprevir and pibrentasvir) is probably not safe if you're breastfeeding. Kindly consult your doctor.
- • Driving: It is advisable not to drive or operate heavy machinery as you may feel dizzy after taking Mavixen 100/40mg Tablet (glecaprevir and pibrentasvir).
- • Kidney: Share your medical history with your healthcare expert in case of kidney disease before taking Mavixen 100/40mg Tablet.
- • Liver: Inform your doctor before starting Glecaprevir and pibrentasvir (Mavixen 100/40mg Tablet) if you have liver disease to avoid any serious side effects.
FAQs About Mavixen 100/40mg Tablet
Why do doctors prescribe Mavixen 100/40mg Tablet (glecaprevir and pibrentasvir)?
This medicine is given to adults diagnosed with hepatitis C virus infection in patients matured 12 years and older.
What is the right way of taking the Mavixen 100/40mg Tablet?
Mavixen Tablet is taken orally with or without food as per the doctor's advice. It is consumed at the same time each day for better results. It is recommended not to crush, chew, or split the capsules; take them as a whole.
What are the commonly observed side effects of Mavixen Tablet?
The most common side effects of this medicine include Diarrhea, Headache, Tiredness, Mouth sores, Muscle or joint pain, Stomach pain, and difficulty breathing. It is advised to go for regular liver function tests to examine the liver function.
Who should avoid taking Mavixen 100/40mg Tablet?
People diagnosed with severe liver and kidney disorders are advised to consult their healthcare professionals before taking this medicine.
References
● Huang, C. F., Kuo, H. T., Chang, T. S., Lo, C. C., Hung, C. H., Huang, C. W., ... & Yu, M. L. (2021). Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan. Scientific reports, 11(1), 23473.
● Poordad, F., Felizarta, F., Asatryan, A., Sulkowski, M. S., Reindollar, R. W., Landis, C. S., ... & Mensa, F. J. (2017). Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct‐acting antiviral treatment. Hepatology, 66(2), 389-397.
● Kwo, P. Y., Poordad, F., Asatryan, A., Wang, S., Wyles, D. L., Hassanein, T., ... & Mensa, F. J. (2017). Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1–6 without cirrhosis. Journal of hepatology, 67(2), 263-271.
● Forns, X., Lee, S. S., Valdes, J., Lens, S., Ghalib, R., Aguilar, H., ... & Mensa, F. J. (2017). Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial. The Lancet infectious diseases, 17(10), 1062-1068.
Gane, E., Lawitz, E., Pugatch, D., Papatheodoridis, G., Bräu, N., Brown, A., ... & Mensa, F. J. (2017). Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment. New England Journal of Medicine, 377(15), 1448-1455.
Marketer Details
Everest
Author Details
Written By:
Nonish Sharma
I am a medical content writer with a strong academic background in life sciences, holding an M.Sc. in Biotechnology... Read More
Reviewed By:
Vaibhav Shakya
Dr. Vaibhav Shakya, MD, is a Medical reviewer and medicine expert at Globans Pharma, with more than 9 years of experienc... Read More
Want to know More
Check our Editor Policy
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.
